Primary cells

Leveraging its extensive clinical sourcing capabilities, Preci has developed a comprehensive platform capable of generating a variety of disease models. These models are supported by detailed histological and molecular data, along with drug action profiles. Through this platform, we can offer researchers access to multiple disease models, seamlessly transferring them for their studies.